Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LVGO

Livongo Health (LVGO) Stock Price, News & Analysis

Livongo Health logo

About Livongo Health Stock (NASDAQ:LVGO)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$139.77
$139.77
50-Day Range
$136.67
$148.08
52-Week Range
$18.76
$151.05
Volume
N/A
Average Volume
3.04 million shs
Market Capitalization
$14.20 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications. Its products include Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company was formerly known as EosHealth, Inc. and changed its name to Livongo Health, Inc. in 2014. Livongo Health, Inc. was incorporated in 2008 and is headquartered in Mountain View, California.

Remove Ads
Receive LVGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Livongo Health and its competitors with MarketBeat's FREE daily newsletter.

LVGO Stock News Headlines

Define Ventures Appoints Bruce Broussard as Venture Partner
I’m prepared to put my reputation on the line…
Brace Yourself for Jeff Bezos' "Amazon Helios" Amazon delivers 20 million packages a day... powers some of the most popular websites... delivers medication to half of the U.S. population... and even produces award-winning films and TV shows. But a Wall Street legend – twice featured on 60 Minutes – predicts that "Amazon Helios" will be bigger than all of those... COMBINED.
David P Fialkow's Net Worth
See More Headlines

LVGO Stock Analysis - Frequently Asked Questions

Livongo Health, Inc. (NASDAQ:LVGO) issued its quarterly earnings results on Wednesday, October, 28th. The company reported $0.16 earnings per share for the quarter, topping the consensus estimate of $0.05 by $0.11. The firm earned $106.10 million during the quarter, compared to the consensus estimate of $95.57 million. Livongo Health had a positive trailing twelve-month return on equity of 0.29% and a negative net margin of 12.20%.

Livongo Health (LVGO) raised $230 million in an initial public offering on Thursday, July 25th 2019. The company issued 10,700,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan acted as the underwriters for the IPO and Piper Jaffray, SVB Leerink, Canaccord Genuity, KeyBanc Capital Markets and Needham & Company were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Livongo Health investors own include NVIDIA (NVDA), Teladoc Health (TDOC), Tesla (TSLA), Meta Platforms (META), PayPal (PYPL) and Salesforce (CRM).

Company Calendar

Last Earnings
10/28/2020
Today
4/02/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Computer Programming, Data Processing, & Other Computer Related
Sub-Industry
N/A
Current Symbol
NASDAQ:LVGO
CIK
N/A
Fax
N/A
Employees
471
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-55,270,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$170.20 million
Price / Cash Flow
N/A
Book Value
$5.37 per share
Price / Book
26.03

Miscellaneous

Free Float
N/A
Market Cap
$14.20 billion
Optionable
Not Optionable
Beta
1.81
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:LVGO) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners